Welcome to the new academic journal OBM Hepatology and Gastroenterology. Recent progress in understanding liver, biliary, pancreatic and gastro-intestinal diseases and their treatments has been observed in the world. OBM Hepatology and Gastroenterology publishes interesting and informative reviews, original articles, and invaluable case reports in this area. We also publish basic research as well as clinical research.

Hepatitis A virus (HAV), HBV, HCV, HDV, and HEV are still a serious issue worldwide. Treatments on these viruses have recently improved. However, liver fibrosis, cirrhosis and hepatocellular carcinoma are still critical conditions. We focus on all of these liver diseases. We also focus on broad-spectrum of gastro-intestinal diseases in this journal.

Please accept our special thanks for choosing to publish in the OBM Hepatology and Gastroenterology. We are looking forward to your submissions for OBM Hepatology and Gastroenterology.

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 6.8 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).

Free Publication in 2021
Current Issue: 2021  Archive: 2020 2019 2018 2017

Special Issue

Gut Microbiota and Gut Health

Submission Deadline: December 31, 2021 (Open) Submit Now

Guest Editor

Rostyslav Bubnov, MD, PhD, LLM

Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kyiv, Ukraine

Website | E-Mail

Research Interests: Microbiome, Metabolic syndrome, Gut health, Probiotics, Prebiotics, Predictive preventive personalized medicine, Radiology, Ultrasound, Lactobacillus, Bifidobacterium

About this Topic

Gut microbiota (GM) has close interaction with human metabolism and immune system. Gut and distant sites microbiome, directly or indirect mechanisms of impact on gut and metabolic health via interaction with intestinal mucosa and producing metabolites. The issue "Gut Microbiota and Gut Health" covers the novel aspects of gut health associated with microbiome, includes contributions on innovative hypotheses, basic research and clinical trials capable to increase the up to date evidence. Studies of complexity of microbial composition and diversity as a potential diagnostic and predictive biomarker and potential targeted treatments based on modulating mirobiome, namely using probiotics, prebiotics, fecal microbiota transplantation (FMT), dietary interventions and novel treatment approaches which need personalization.


Open Access Review

The Effects of Mediterranean Diet on the Human Gut Microbiota; a Brief Discussion of Evidence in Humans

Received: 09 November 2020;  Published: 05 February 2021;  doi: 10.21926/obm.hg.2101056


The Mediterranean diet (MD) is considered one of the healthiest dietary patterns due to its rich provision of phytochemicals, antioxidants, vitamins, fiber, polyunsaturated, omega-3, and short-chain fatty acids through a variety of foods. The supply of such nutrients and bioactive components can sup [...]
Open Access Commentary

Deconstructing then Priming Gut Microbiota Resilience

Received: 11 December 2020;  Published: 01 February 2021;  doi: 10.21926/obm.hg.2101055


The human intestinal microbiota represents a complex microbial community that plays an essential role in the maintenance of host health. Over the last decade, metagenomic and metabolomic analyses have revealed the influence of intestinal microbial diversity and composition on a range of biological f [...]
Open Access Original Research

Multi-Species Probiotic Modulates Cytokine Production and the Interplay between Immune and Colon Cancer Cells

Received: 28 June 2020;  Published: 19 November 2020;  doi: 10.21926/obm.hg.2004053


The current study aimed to investigate the effect of a multi-species probiotic (MSP) on cytokine production by human peripheral blood mononuclear cells (PBMCs) and their immune dialogue with HT-29 colon cancer cells. PBMCs were incubated with MSP and their effect on cell proliferation and TNFα, IL-1 [...]